Current News

The current migration and asylum policies of the Federal Republic of Germany and the EU seriously violate the right to health and the physical and psychological integrity of migrant and refugee peoples. This is the result of the Human Rights Tribunal organized by an alliance of civil society organizations in Berlin at the weekend.

 

“The reports of fugitives and their supporters paint a frightening picture of German and European migration policy” summarized juror Sarah Lincoln. “Many of the refugees are sick and need special protection. Instead, they are treated like second-class citizens, without privacy, without access to adequate health care, without procedural rights”.

[...] read more

One of the many dangers of COVID-19 is the disease's mysterious ability to promote blood clots throughout the body. Now, a new study may explain why — the disease appears to spur the production of special antibodies known to trigger blood clots. These so-called "autoimmune antibodies" or "autoantibodies" attack a person's own tissues. Specific types of autoantibodies called "antiphospholipid autoantibodies" attack cells in such a way as to promote blood clots. In the study, published Nov. 2 in the journal Science Translational Medicine, researchers detected these autoantibodies in about half of patients hospitalized with COVID-19.

[...] read more

In The Lancet, Brian Ward and colleagues report two efficacy studies that are, to the best of my knowledge, the first randomised phase 3 trials of a plant-derived quadrivalent influenza vaccine.[1] The vaccine material was generated in Nicotiana benthamiana, a relative of the tobacco plant. The plants were transfected with an attenuated plant viral vector (Agrobacterium tumefaciens) expressing influenza haemagglutinin genes and the vaccine was recovered from the transfected plants in the form of virus-like particles.

[...] read more

A man in the U.K. developed sudden and permanent hearing loss in one ear after battling a severe case of COVID-19, according to a new report. His doctors are now warning others to be on the lookout for this rare but serious complication, which has been reported in a handful of COVID-19 patients around the world.

[...] read more

Further notification

The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results of a large, international trial.

[...] read more

Even as vaccines are hailed as our best hope against the coronavirus, dozens of scientific groups are working on an alternate defense: monoclonal antibodies. These therapies shot to prominence just this month after President Trump got an infusion of an antibody cocktail made by Regeneron and credited it for his apparent recovery, even calling it a “cure.”

[...] read more

The coronavirus treatment President Trump praised as his “cure” was created using a cell line derived from an aborted fetus.

 

President Trump has lauded the experimental treatment he received for his coronavirus infection, releasing one enthusiastic video on Wednesday and another today.

 

In Wednesday’s video, Mr. Trump called the cocktail of monoclonal antibodies being developed by the drug maker Regeneron “a cure,” a term he repeated today. He said he would make the treatment free to anyone who needed it, stressing “the seniors” in today’s video.

[...] read more

President Donald Trump received an unapproved antibody cocktail as part of his coronavirus treatment, making him one of fewer than 10 people to get the drug outside of a clinical trial, Stat News reported.

[...] read more

Newsletter

Please just subscribe for our newsletter on this topics:

  • Anaesthesia / Intensive care
  • Psychotherapy / Psychiatry
  • Business psychology


Here you can subscribe very easy.

 

MAGAZINES

Discover our selection of regular journals:

To the magazines

 

INTERNATIONAL


Discover our selection of German-language publications:

To the German page